Who is sponsoring NCT06062862?

NCT06062862 is sponsored by Cairo University.

What drugs are being tested in NCT06062862?

Interventions in NCT06062862: The Incentive Spirometer, The breather respiratory muscle training device.

What condition does NCT06062862 study?

NCT06062862 studies Pneumonia Hospital Acquired.

Is NCT06062862 still recruiting?

NCT06062862 is currently completed. Last updated 2 October 2023.

Last reviewed 2023-10-02 · How we verify

NCT06062862

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Breather on Hospital Stay in Patients With Acquired Pneumonia

Completed NA Last updated 2 October 2023

What this trial tests

NA trial testing The Incentive Spirometer in Pneumonia Hospital Acquired in 60 participants. Completed in 30 April 2023.

Timeline

30 April 2022

Primary endpoint
30 October 2022

30 April 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	30 April 2022
Primary completion	30 October 2022
Estimated completion	30 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

The Incentive Spirometer
The breather respiratory muscle training device

Conditions studied

Pneumonia Hospital Acquired — all drugs for Pneumonia Hospital Acquired →

Sponsor

Cairo University

Who can join

Adults 30 to 40, any sex, with Pneumonia Hospital Acquired. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acquired pneumonia is a sever medical condition that addressed as life-threatening issue require intensive care. Medical Breather device permits activating and strengthening of both inspiratory and expiratory musculatures; thus, it could be useful for pneumatic patients. The aim of the study is to investigate breather effect on hospital stay in pneumatic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06062862 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 2 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06062862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing